Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer

1. González Martín, A.
2. Oza, A.M.
3. Embleton, A.C.
4. Pfisterer, J.
5. Ledermann, J.A.
6. Pujade-Lauraine, E.
7. Kristensen, G.
8. Bertrand, M.A.
9. Beale, P.
10. Cervantes, A.
11. Kent, E.
12. Kaplan, R.S.
13. Parmar, M.K.B.
14. Scotto, N.
15. Perren, T.J.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1016/J.YGYNO.2018.08.036 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus